|

Any Chinese government-recommended COVID-19 booster vaccine Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Peking Union Medical College Hospital1

Indications

  • Antibody1
  • COVID-19 Recurrent1
  • Vaccination1
  • Immune Checkpoint Inhibitor1
  • Lung Cancer1

Other1 trial

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.